Journal of Hepatology, 78(5), 947-957. Elsevier Journal of hepatology, 78(5), 947-957. Elsevier Journal of Hepatology, 78, 5, pp. 947-957 the Swiss HIV Cohort Study, EuroSIDA, ATHENA Observational Cohort Study & ANRS CO3 Aquitaine Cohort 2023, ' External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection ', Journal of Hepatology, vol. 78, no. 5, pp. 947-957 . https://doi.org/10.1016/j.jhep.2022.12.029 Journal of Hepatology, 78(5), 947-957. ELSEVIER SCIENCE BV Journal of Hepatology Journal of Hepatology, 2023, 78 (5), pp.947-957. ⟨10.1016/j.jhep.2022.12.029⟩ Surial, Bernard; Ramírez Mena, Adrià; Roumet, Marie; Limacher, Andreas; Smit, Colette; Leleux, Olivier; Mocroft, Amanda; van der Valk, Marc; Bonnet, Fabrice; Peters, Lars; Rockstroh, Jürgen K; Günthard, Huldrych F; Berzigotti, Annalisa; Rauch, Andri; Wandeler, Gilles (2023). External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Journal of hepatology, 78(5), pp. 947-957. Elsevier 10.1016/j.jhep.2022.12.029
Lancet HIV, 8(2), e96-e105. ELSEVIER SCIENCE INC ATHENA observational cohort 2021, ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ', The Lancet HIV, vol. 8, no. 2, pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5 Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8, 2, pp. e96-e105 The Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8(2), e96-e105. Elsevier Ltd. The Lancet HIV, 8, e96-e105 The Lancet HIV, 8(2), E96-E105. ELSEVIER INC
Clinical Microbiology and Infection, 25(4), 518-520. ELSEVIER SCI LTD Clinical Microbiology and Infection, 25(4), 518-520. Elsevier Ltd. van Prehn, J, van Triest, M I, Altorf-van der Kuil, W, van Dijk, K, Stuart, J W T C, Weersink, A J L, Notermans, D, van Ogtrop, M L, Jager, M M, Werdmuller, B F M, van Hees, B C, van Keulen, P H J, Alblas, J, Blijboom, L, de Greeff, S C, Groenendijk, S, van Heereveld, J, Hertroys, R, Monen, J C, Notermans, D W, Reuland, E A, Schoffelen, A F, Wielders, C C H, Woudt, S H S, Kluytmans, J A J W, Kraan, E M, Mattsson, E E, Sebens, F W, de Jong, E, Frénay, H M E, Maraha, B, van Griethuysen, A J, Demeulemeester, A, Wintermans, B B, van Trijp, M, Ott, A, e. Bathoorn, Lokate, M, Sinnige, J, de Brauwer, E I G B, Stals, F S, van Dam, D W, Overdevest, I T M A, van Dijk, K, Jager, M M, Reuland, E A, Kluytmans, J A J W, de Jong, E, Wintermans, B B, Overdevest, I T M A, the Dutch National AMR Surveillance Study Group, Trienekens, T, Ruijs, G J H M & Wolfhagen, M J H M 2019, ' Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands ', Clinical Microbiological and Infection, vol. 25, no. 4, pp. 518-520 . https://doi.org/10.1016/j.cmi.2018.11.021 Clinical Microbiology and Infection, 25(4), 518-520 Clinical Microbiological and Infection, 25(4), 518-520